It was a factor I applied to NPAT (FY18 vs FY17).
Alternative growth valuation post results announcements (assume last week of August - instead of June)
FY15 (31/8 SP $0.63, MC of $0.42b)
FY16 (29/8 SP $1.82, MC of $1.32b) – NPAT of $30.4m
FY17 (28/8 SP $5.11, MC of $3.75b) – NPAT of $90.6m
- MC from FY17 vs FY16 was a factor of 2.84 vs NPAT factor of 2.98 (relatively aligned) or roughly 3x
FY18 (27/8 SP $11.50, MC of $8.43b) – NPAT of $195.7m
- MC from FY18 vs FY17 was a factor of 2.25 vs NPAT factor of 2.16 (relatively aligned) or roughly 2x
FY19F NPAT of $280m (estimate assuming sales of $1.32b, similar NPAT ratio to FY18)
- FY19F vs FY18 NPAT factor of 1.43 or roughly 1.4x
FY19F SP should technically be equivalent to $11.50 x 1.43 or $16.44 (MC of >$12b), hence A2M is extremely undervalued at $10.58 (over 55% upside in my opinion) and that is being very conservative.
Good luck holders.
- Forums
- ASX - By Stock
- A2M
- Investment Fundamentals
Investment Fundamentals, page-5
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.25 |
Change
0.510(8.89%) |
Mkt cap ! $4.467B |
Open | High | Low | Value | Volume |
$6.24 | $6.77 | $6.05 | $29.65M | 4.654M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 231 | $6.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.46 | 919 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 230 | 6.510 |
20 | 782 | 6.380 |
1 | 78 | 6.370 |
3 | 18675 | 6.320 |
1 | 620 | 6.300 |
Price($) | Vol. | No. |
---|---|---|
5.460 | 919 | 1 |
6.020 | 380 | 40 |
6.060 | 4826 | 15 |
6.080 | 4651 | 5 |
6.090 | 2691 | 6 |
Last trade - 11.20am 27/09/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |